Proteus Pharmaceuticals Private Limited

Proteus Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24230MH2004PTC145936 Incorporated 27 April 2004 ROC Mumbai HQ Mumbai, Maharashtra, India
Under Liquidation Private Limited Company pharma
Data last updated
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹153.8 Cr
Secured borrowings
Company age
22 yrs
Est. 2004
Directors on board
2
As per MCA filings
Last financials
Mar 2008
Balance sheet date
Last AGM
30 Sep 2008
Annual general meeting
Company status
Under Liquidation
MCA master data

About Proteus Pharmaceuticals Private Limited

Data last updated:

Proteus Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 April 2004.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC145936.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹40 Lakh. It is led by directors Ramesh Purshottamdas Mehta and Alpesh Shashikant Mehta.

Its last annual general meeting (AGM) was held on 30 September 2008, and its latest financial statements are for the year ended 31 March 2008. The registered office is at 705 Godavari Svp Nagarmhada Layout Andheri (W), Mumbai, Maharashtra, India – 400053.

As per MCA filings, the company has open charges of ₹153.8 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.

Company Details of Proteus Pharmaceuticals Private Limited
CIN U24230MH2004PTC145936
Registration Number 145936
Incorporation Date 27 April 2004
ROC Mumbai
Listing Status Unlisted
Company Status Under Liquidation
Date of Last AGM 30 September 2008
Date of Balance Sheet 31 March 2008
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    705 Godavari Svp Nagarmhada Layout Andheri (W), Mumbai, Maharashtra, India – 400053
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Proteus Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Proteus Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Proteus Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Financials of Proteus Pharmaceuticals Private Limited FY 2008 filings available

Financial Statement Summary of Proteus Pharmaceuticals Private Limited

MetricsFY 2007-08
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA••••
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)••••
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios of Proteus Pharmaceuticals Private Limited

MetricsFY 2007-08
Profitability
EBITDA Margin••••
Net Profit Margin••••
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Proteus Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Proteus Pharmaceuticals Private Limited

Proteus Pharmaceuticals has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Ramesh Purshottamdas MehtaDirector03 Jan 200620 Years 9 MonthsAs last reported
Alpesh Shashikant MehtaDirector10 Oct 200520 Years 11 MonthsAs last reported

Charges & Borrowings of Proteus Pharmaceuticals Private Limited

Open charges
₹153.8 Cr
Satisfied charges
None
Breakdown by lending institutions
Edelweiss Asset Reconstruction Company Limited₹96.50 Cr
The Lakshmivilas Bank Limited₹30.00 Cr
Canara Bank₹17.30 Cr
Global Trade Finance Limited₹10.00 Cr
Latest charge details
DateLenderAmountStatus
23 Jan 2010Edelweiss Asset Reconstruction Company Limited₹48.25 CrOpen
18 Jun 2009Global Trade Finance Limited₹10 CrOpen
17 Mar 2009The Lakshmivilas Bank Limited₹25 CrOpen
23 Dec 2008The Lakshmivilas Bank Limited₹5 CrOpen
18 Oct 2008Edelweiss Asset Reconstruction Company Limited₹48.25 CrOpen

Total charge records: 8 View all charges

Employees and EPFO Compliance at Proteus Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Proteus Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Proteus Pharmaceuticals Private Limited

Proteus Pharmaceuticals Private Limited has 2 board changes on record since 2005: 2 appointments. The latest: Ramesh Purshottamdas Mehta was appointed as Director on 03 Jan 2006.

Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 48.25 Cr registered on 23 Jan 2010 with Charge ID 10203915 was modified on 11 Feb 2011.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited of Rs. 48.25 Cr registered on 18 Oct 2008 with Charge ID 10128591 was modified on 11 Feb 2011.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited amounted to Rs. 48.25 Cr with Charge ID 10203915 was registered on 23 Jan 2010.
Charges
A charge with Global Trade Finance Limited amounted to Rs. 10.00 Cr with Charge ID 10161394 was registered on 18 Jun 2009.
Charges
A charge with The Lakshmivilas Bank Limited of Rs. 25.00 Cr registered on 17 Mar 2009 with Charge ID 10154742 was modified on 11 May 2009.
Charges
A charge with The Lakshmivilas Bank Limited of Rs. 5.00 Cr registered on 23 Dec 2008 with Charge ID 10141476 was modified on 11 May 2009.
Charges
A charge with The Lakshmivilas Bank Limited amounted to Rs. 25.00 Cr with Charge ID 10154742 was registered on 17 Mar 2009.
Charges
A charge with The Lakshmivilas Bank Limited amounted to Rs. 5.00 Cr with Charge ID 10141476 was registered on 23 Dec 2008.
Charges
A charge with Edelweiss Asset Reconstruction Company Limited amounted to Rs. 48.25 Cr with Charge ID 10128591 was registered on 18 Oct 2008.
AGM
Proteus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2008 as per latest MCA records.
Filing
Proteus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2008 with Roc Mumbai.
Charges
A charge with Canara Bank of Rs. 8.00 Cr registered on 29 Mar 2005 with Charge ID 90353621 was modified on 16 May 2007.

6 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Proteus Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Proteus Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Proteus Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Proteus Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Proteus Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Proteus Pharmaceuticals Private Limited

Proteus Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.

Proteus Pharmaceuticals is a company under liquidation, formerly operating as a private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 April 2004 and is registered under CIN U24230MH2004PTC145936. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Proteus Pharmaceuticals has 2 current directors:

The CIN (Corporate Identification Number) of Proteus Pharmaceuticals is U24230MH2004PTC145936. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Proteus Pharmaceuticals has open charges of ₹153.8 Cr and no satisfied charges on record as per latest MCA filings.

Proteus Pharmaceuticals has 3 court cases on record: 3 filed against it. 2 are pending. Most are in the district courts.

Proteus Pharmaceuticals was incorporated on 27 April 2004. It is registered with the Registrar of Companies, Mumbai.

Ramesh Purshottamdas Mehta was appointed as Director on 03 Jan 2006. Alpesh Shashikant Mehta was appointed as Director on 10 Oct 2005.

The registered office of Proteus Pharmaceuticals is at 705 Godavari Svp Nagarmhada Layout Andheri W, Mumbai, Maharashtra, India – 400053.

Proteus Pharmaceuticals has an authorised share capital of ₹2 Cr and a paid-up capital of ₹40 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available